EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GL67 lipid-based liposomal formulation for efficient siRNA delivery into human lung cancer cells

Somayah J Jarallah, Ahmad M Aldossary, Essam A Tawfik, Reem M Altamimi, Wijdan K Alsharif, Nouf M Alzahrani, Homood M As Sobeai, Wajhul Qamar, Ahmed J Alfahad, Manal A Alshabibi, Sarah H Alqahtani, Abdullah A Alshehri und 1 weitere

Saudi Pharmaceutical Journal · 2023-07 · 31 (7) · 1139-1148

DOI: 10.1016/j.jsps.2023.05.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saudi Pharmaceutical Journal, 2023-07. Verfasst von Somayah J Jarallah und 12 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: King Abdulaziz City for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficient delivery of small interfering RNA (siRNA) to the targeted cells significantly affects the regulation of the overexpressed proteins involved in the progression of several genetic diseases. SiRNA molecules in naked form suffer from low internalization across the cell membrane, high susceptibility to degradation by nuclease enzyme and low stability, which hinder their efficacy. Therefore, there is an urge to develop a delivery system that can protect siRNA from degradation and facilitate their uptake across the cell membrane. In this study, the cationic lipid (GL67) was exploited, in addition to DC-Chol and DOPE lipids, to design an efficient liposomal nanocarrier for siRNA delivery. The physiochemical characterizations demonstrated that the molar ratio of 3:1 has proper particle size measurements from 144 nm to 332 nm and zeta potential of -9 mV to 47 mV that depends on the ratio of the GL67 in the liposomal formulation. Gel retardation assay exhibited that increasing the percentage of GL67 in the formulations has a good impact on the encapsulation efficiency compared to DC-Chol. The optimal formulations of the 3:1 M ratio also showed high metabolic activity against A549 cells following a 24 h cell exposure. Flow cytometry findings showed that the highest GL67 lipid ratio (100 % GL67 and 0 % DC-Chol) had the highest percentage of cellular uptake. The lipoplex nanocarriers based on GL67 lipid could potentially influence treating genetic diseases owing to the high internalization efficiency and safety profile.

Schlagwörter

Stichwörter der Autor:innen

A549 cellsGL67 lipidGene therapyLiposomessiRNA delivery

Autor:innen und Institutionen

  • Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.
  • Wellness and Preventative Medicine Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.
  • Pharmacology and Toxicology Department, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Bioengineering Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.
  • Healthy Aging Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.

Förderung

  • King Abdulaziz City for Science and Technology

Zitieren

APA

Jarallah, S. J., Aldossary, A. M., Tawfik, E. A., Altamimi, R. M., Alsharif, W. K., Alzahrani, N. M., As Sobeai, H. M., Qamar, W., Alfahad, A. J., Alshabibi, M. A., Alqahtani, S. H., Alshehri, A. A., & Almughem, F. A. (2023). GL67 lipid-based liposomal formulation for efficient siRNA delivery into human lung cancer cells. Saudi Pharmaceutical Journal, 31(7), 1139-1148. https://doi.org/10.1016/j.jsps.2023.05.017

Vancouver

Jarallah SJ, Aldossary AM, Tawfik EA, Altamimi RM, Alsharif WK, Alzahrani NM, et al. GL67 lipid-based liposomal formulation for efficient siRNA delivery into human lung cancer cells. Saudi Pharmaceutical Journal. 2023;31(7):1139-1148. doi:10.1016/j.jsps.2023.05.017

BibTeX
@article{Jarallah2023,
  author = {Jarallah, Somayah J and Aldossary, Ahmad M and Tawfik, Essam A and Altamimi, Reem M and Alsharif, Wijdan K and Alzahrani, Nouf M and As Sobeai, Homood M and Qamar, Wajhul and Alfahad, Ahmed J and Alshabibi, Manal A and Alqahtani, Sarah H and Alshehri, Abdullah A and Almughem, Fahad A},
  title = {GL67 lipid-based liposomal formulation for efficient siRNA delivery into human lung cancer cells},
  journal = {Saudi Pharmaceutical Journal},
  year = {2023},
  volume = {31},
  number = {7},
  pages = {1139--1148},
  doi = {10.1016/j.jsps.2023.05.017}
}
Kostenlos starten →